Tai Chi and Laughing Therapy for Improving Functions of Frail Older Adults (AA project)

July 23, 2026 updated by: Rhayun Song, Chungnam National University

Effect of Tai Chi and Laughing Therapy on Physical and Cognitive Function Among Frail Older Adults

The goals of this study are to examine the physical function, cognitive function, and quality of life among frail elderly residing in the community

Study Overview

Status

Completed

Conditions

Detailed Description

This randomized clinical trial recruited 150 frail older adults, assigned to either the intervention groups (Tai Chi vs. Laughing therapy) or the wait-list control group. Tai Chi intervention provided to the Tai Chi group for 12 weeks with 12-week follow-up and pretest and posttest measures will be conducted. Laughing therapy intervention provided 10 weekly sessions for 12 weeks.

The primary outcome is the function variables (physical function of balance, flexibility, mobility; cognitive function of MOCA-K) The secondary outcome is quality of life measured by SF36, and healthy aging measured by healthy aging scale.

Study Type

Interventional

Enrollment (Actual)

150

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Daejeon, South Korea, 35015
        • Chungnam National University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

61 years to 81 years (Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • being frail (3 out of the following 5 criteria): feeling fatigued, difficulty climbing 10 stairs without help, difficulty walking 300m without help, more than 5 chronic illness, weight loss 5 % or more past 1-5 years
  • living in the community
  • able to participate in Tai Chi program twice a week

Exclusion Criteria:

  • participated in any formal exercise program past 6 months
  • not have transportation to come to the class

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: frail elderly-WC
control group received no intervention for 12 weeks, and will be provided the chance to participate in Tai Chi program if they choose.
Experimental: social interaction based intervention
Laughing therapy group received 10 sessions, weekly, 60 min per session led by a certified LT instructor
10 sessions of laughing therapy by a certified instructor
Experimental: Exercise based intervention
Sun style Tai Chi program was provided twice per week, one hour per session for 12 weeks by a certified TC instructor
Sun-style Tai Chi (21 forms)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
physical function - balance
Time Frame: changes from pretest to 12 week posttest scores
balance was assessed using a one-leg-standing balance test (OLST)
changes from pretest to 12 week posttest scores
physical function - flexibility
Time Frame: changes from pretest to 12 week posttest scores
flexibility was assessed by the standard sit-and-reach test (SSRT)
changes from pretest to 12 week posttest scores
physical function - mobility
Time Frame: changes from pretest to 12 week posttest scores
mobility was assessed by the Timed Up and Go test (TUG)
changes from pretest to 12 week posttest scores
cognitive function
Time Frame: changes from pretest to 12 week posttest scores
MOCA-K (Korean version of Montreal Cognitive Assessment) was used with the maximum score of 30. (more than 23 is normal and less than 13 is dementia, more cognitively impaired)
changes from pretest to 12 week posttest scores

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Short Form health survey 36 (SF36)
Time Frame: changes from pretest to 12 week posttest scores
Short Form health survey 13 which consists of eight dimensions: general health, physical functioning, role physical, body pain, vitality, social functioning, role emotional, and mental health. two summary scores for the physical and mental components of health-related QoL are calculated by using the weighted means for the eight domains. Higher scores indicate better health-related QoL.
changes from pretest to 12 week posttest scores

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Rhayun Song, PhD, Chungnam National University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2023

Primary Completion (Actual)

October 30, 2025

Study Completion (Actual)

November 5, 2025

Study Registration Dates

First Submitted

November 12, 2022

First Submitted That Met QC Criteria

November 17, 2022

First Posted (Actual)

November 29, 2022

Study Record Updates

Last Update Posted (Actual)

July 24, 2026

Last Update Submitted That Met QC Criteria

July 23, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

unidentified data or study protocol can be shared at the completion of publication

IPD Sharing Time Frame

December, 2025

IPD Sharing Access Criteria

researchers or reviewers with request

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe